The harms and benefits of modern screening mammography.
نویسندگان
چکیده
18 June 2014 It is difficult to understand why Drs. Elmore and Harris, two professors of medicine, are so much against early diagnosis and treatment of breast cancer in its early stages. They are commenting on mammography screening, but the real issue is early detection of the disease. They propose women not be diagnosed early because there is access to very expensive chemotherapy treatment with short and long lasting physical, cognitive, emotional and psychological damage; also, the advanced stage of the disease causes real human suffering. Their comments about the impact of treatment are speculation taken from thin air, without any supporting data. Without individual patient data nobody can tell the relative benefit of treatment versus screening, and none of those authors who are against screening have access to individual patient data!
منابع مشابه
The value of modern mammography screening in the control of breast cancer: understanding the underpinnings of the current debates.
Since the introduction of mammography screening, debates about the value of screening have endured and been contentious. Recent reviews of the randomized controlled trials reach different conclusions about the absolute benefit of screening, as do evaluations of population trends in breast cancer mortality and the evaluations of service screening. Conclusions about the value of screening commonl...
متن کاملAre benefits and harms in mammography screening given equal attention in scientific articles? A cross-sectional study
BACKGROUND The CONSORT statement specifies the need for a balanced presentation of both benefits and harms of medical interventions in trial reports. However, invitations to screening and newspaper articles often emphasize benefits and downplay or omit harms, and it is known that scientific articles can be influenced by conflicts of interest. We wanted to determine if a similar imbalance occurs...
متن کاملScreening mammography in older women: a review.
IMPORTANCE Guidelines recommend individualizing screening mammography decisions for women aged 75 years and older. However, little pragmatic guidance is available to help counsel patients. OBJECTIVE To provide an evidence-based approach for individualizing decision-making about screening mammography in older women. EVIDENCE ACQUISITION We searched PubMed for English-language studies in peer...
متن کاملCollaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
BACKGROUND Controversy persists about optimal mammography screening strategies. OBJECTIVE To evaluate screening outcomes, taking into account advances in mammography and treatment of breast cancer. DESIGN Collaboration of 6 simulation models using national data on incidence, digital mammography performance, treatment effects, and other-cause mortality. SETTING United States. PATIENTS Av...
متن کاملCounseling Women About Breast Cancer Screening.
Breast cancer is one of the most common malignancies among women, with approximately 3% of women dying from the disease and approximately 12% of those who live to 80 years of age being diagnosed with it at some point during their lifetime.1 Although screening mammography reduces breast cancer–specific mortality, women may overestimate its benefit.2 Biennial mammography is recommended for all wo...
متن کاملScreening mammography: sparing the emperor's blushes
Differing interpretations about evidence on benefits and harms of screening mammography has led to conflicting recommendations among different jurisdictions that range from intensive screening starting at age 40 to no screening at all. Despite broad attention of scientific and nonscientific media, evidence suggests substantial discrepancy between real and perceived benefits of screening mammogr...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- BMJ
دوره 348 شماره
صفحات -
تاریخ انتشار 2014